UK Specialty Chemicals Maker Croda Hikes Prices to Offset Higher Costs Amid Mideast War
Published by Global Banking & Finance Review®
Posted on April 22, 2026
2 min readLast updated: April 22, 2026
Add as preferred source on Google
Published by Global Banking & Finance Review®
Posted on April 22, 2026
2 min readLast updated: April 22, 2026
Add as preferred source on Google
Croda International is hiking prices to counter rising input costs spurred by the Middle East conflict, while reaffirming its full-year and 2028 ambitions amid resilience driven by strong demand in beauty, agro and pharma segments.

(Corrects syntax in paragraph 3)
April 22 (Reuters) - British specialty chemicals maker Croda International said on Wednesday it is raising prices to offset input cost inflation since the start of the Middle East conflict, as it affirmed its annual and medium term targets.
The chemicals company, which had been streamlining operations and tightening procurement to offset a weaker market after U.S. tariffs, now also faces the risk of higher costs from surging energy prices due to the U.S.-Israeli war against Iran.
The firm said it is monitoring the situation in the Middle East and will pass on rising input costs to clients through price increases, in line with hikes from early 2025 amid inflationary pressures triggered by U.S. tariffs.
The company, which provides ingredients for the beauty, agriculture, and pharmaceutical industries, said its revenue for the three months ended March 31, rose 1% to 431 million pounds ($582.45 million)on a constant currency basis, helped by strong demand for its beauty actives, including fragrances ad flavours.
It reaffirmed its annual outlook and ambitions it had set for until 2028 in February.
($1 = 0.7400 pounds)
(Reporting by Prerna Bedi in Bengaluru; Editing by Sherry Jacob-Phillips)
Croda is raising prices to offset higher input costs caused by inflation and energy price surges tied to the Middle East conflict.
Croda supplies chemicals and ingredients for the beauty, agriculture, and pharmaceutical industries.
The Middle East conflict has increased input and energy costs, prompting Croda to adjust pricing and closely monitor ongoing risks.
Croda's revenue rose 1% to 431 million pounds for the three months ended March 31, 2024, supported by strong demand for beauty actives.
Yes, Croda reaffirmed both its annual outlook and its medium-term targets through 2028 despite current market challenges.
Explore more articles in the Finance category



